Certain conditions originating in the perinatal period. Other specified conditions originating in the perinatal period
Conditions
Interventions
Intervention 1: Intervention group: 2000 units of vitamin D daily from week 26 to 36 of pregnancy. Intervention 2: Control group: Placebo from week 26 to 36 of pregnancy.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: The desire to participate in the study Do not take vitamin D supplementation routinely Inadequate levels of vitamin D (serum 25 hydroxyvitamin D 50 to 80 nmol per liter or between 20 and 32 ng / ml) Lack of any of the diseases: rheumatoid arthritis, thyroid disease, parathyroid disease, liver disease, kidney failure, metabolic bone disease, diabetes mellitus, type 1 diabetes, gestational diabetes, malabsorption, and the use of drugs that affect vitamin D.
Exclusion criteria
Exclusion criteria: Cancellation of the continuation of the study Sensitivity to vitamin D tablets Preterm delivery Gestational Diabetes Preeclampsia Difficult Delivery Asphyxia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting sugar - Sugar 2 hours after breakfast. Timepoint: 26 weeks and 36 week pregnancy. Method of measurement: Glucometer Bionime.;Systolic and diastolic pressure. Timepoint: 26 weeks before intervention and 36 week. Method of measurement: Blood pressure system.;Lipid profile. Timepoint: 26 weeks and 36 week of pregnancy. Method of measurement: Kitbiorex.;Anthropometric characteristics (height, weight, round head). Timepoint: after birth. Method of measurement: metric system.;Apgar. Timepoint: after birth. Method of measurement: Apgar system.;2 hpp. Timepoint: 26 weeks and 36 week of pregnancy. Method of measurement: Glucometer Bionime. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehrnaz Radmehr
Shiraz University of Medical Sciences
Outcome results
None listed